A 24-week open-label Phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir)
Year: 1996
Type: article
Study design: Clinical Trial
Source: AIDS
Institution: Albany Medical College
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: indinavir, HIV protease inhibitors, HIV infection, pharmacokinetics, drug safety, CD4 count, viral load, soluble TNF receptor 2, antiretroviral therapy, mathematical modeling, two-compartment model, sigmoid Emax model, oral bioavailability, drug-drug interactions, adverse events, treatment-naive patients, treatment-experienced patients
Open Access status: closed
OpenAlex ID: W2078326422
